An electrocardiogram-based AI algorithm for early detection of pulmonary hypertension

June 25 2024

Background Early diagnosis of pulmonary hypertension (PH) is critical for effective treatment and management. We aimed to develop and externally validate an artificial intelligence algorithm that could serve as a PH screening tool, based on analysis of a standard 12-lead ECG. Methods The PH Early Detection Algorithm (PH-EDA) is a convolutional neural network developed using retrospective ECG voltage–time data, with patients classified as “PH-likely” or “PH-unlikely” (controls) based on right heart catheterisation or echocardiography. In total, 39 823 PH-likely patients and 219 404 control patients from Mayo Clinic were randomly split into training (48%), validation (12%) and test (40%) sets. ECGs taken within 1 month of PH diagnosis (diagnostic dataset) were used to train the PH-EDA at Mayo Clinic. Performance was tested on diagnostic ECGs within the test sets from Mayo Clinic (n=16 175/87 998 PH-likely/controls) and Vanderbilt University Medical Center (VUMC; n=6045/24 256 PH-likely/controls). In addition, performance was tested on ECGs taken 6–18 months (pre-emptive dataset), and up to 5 years prior to a PH diagnosis at both sites. Results Performance testing yielded an area under the receiver operating characteristic curve (AUC) of 0.92 and 0.88 in the diagnostic test sets at Mayo Clinic and VUMC, respectively, and 0.86 and 0.81, respectively, in the pre-emptive test sets. The AUC remained a minimum of 0.79 at Mayo Clinic and 0.73 at VUMC up to 5 years before diagnosis. Conclusion The PH-EDA can detect PH at diagnosis and 6–18 months prior, demonstrating the potential to accelerate diagnosis and management of this debilitating disease.

Authors:

Hilary M. DuBrock, Tyler E. Wagner, Katherine Carlson, Corinne L. Carpenter, Samir Awasthi, Zachi I. Attia, Robert P. Frantz, Paul A. Friedman, Suraj Kapa, Jeffrey Annis, Evan L. Brittain, Anna R. Hemnes, Samuel J. Asirvatham, Melwin Babu, Ashim Prasad, Unice Yoo, Rakesh Barve, Mona Selej, Peter Agron, Emily Kogan, Deborah Quinn, Preston Dunnmon, Najat Khan, Venky Soundararajan

nference, Inc Anumana, Inc Mayo Clinic, USA

nference

Anumana

Mayo Clinic

Correspondence to:

Hilary M. DuBrock (dubrock.hilary@mayo.edu)